Product Code: GVR-2-68038-697-4
Cardiovascular Ultrasound Market Growth & Trends:
The global cardiovascular ultrasound market size is expected to reach USD 3.52 billion by 2030 and expand at a CAGR of 5.41% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factor driving cardiovascular ultrasounds is that new imaging technologies have improved the accuracy and resolution of images obtained from echocardiography machines. This makes it easier for clinicians to identify and diagnose diseases. Additionally, it provides non-invasive diagnostic options, which are often preferred over invasive procedures.
Benefits associated with cardiovascular ultrasound over conventional methods include quick recovery, reduced span of hospitalization, and fewer post-operative complications. These benefits along with the rising geriatric population are expected to propel the demand for cardiovascular ultrasound diagnosis over the forecast period.
North America captured the largest market share in 2022. A favorable reimbursement framework and the presence of a large number of industry players are some of the major factors which can be attributed to regional growth. The rising geriatric population coupled with sophisticated healthcare infrastructure is expected to further fuel market growth in the region. Furthermore, increasing health awareness is driving demand.
COVID-19 has had a significant impact on CVUS. One of the most noticeable effects of the pandemic has been the delays in elective procedures, including those related to CVUS. As a result, which reduces the demand for imaging equipment and services. However, the pandemic has also led to an increase in telemedicine adoption, which includes the use of remote monitoring devices and virtual consultations. This led to increased use of portable devices and an expansion of the market.
Cardiovascular Ultrasound Market Report Highlights:
- The transthoracic echocardiography (TTE) segment dominated the market by capturing a share of 55.4% in 2023.
- The doppler segment dominated the market by capturing a 42.6% share in 2023 and is further expected to grow at the fastest CAGR over the forecast period. This is primarily attributed to its advanced capabilities in providing detailed blood flow and velocity measurements.
- The color segment dominated the market by capturing a share of 84.0% in 2023 and is expected to grow at the fastest rate over the forecast period. This is primarily attributed to its superior ability to visualize and assess blood flow dynamics within the heart and vascular system.
- The hospital segment dominated the market with a share of over 45.9% in 2023. This dominance is attributed to several factors, including the increasing number of outpatient department (OPD) visits and hospital admissions.
- North America cardiovascular ultrasound market held the largest share of 29.0% in 2023. This can be attributed to the presence of a robust healthcare infrastructure that facilitates the widespread adoption of advanced medical technologies, including cardiovascular ultrasound.
- The cardiovascular ultrasound market in Asia Pacific is estimated to witness the fastest CAGR of 5.82% during the forecast period, primarily due to the rapid expansion of healthcare infrastructure and increasing investments in advanced medical technologies across the region.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Technology
- 1.2.3. Display
- 1.2.4. End Use
- 1.2.5. Regional scope
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Technology outlook
- 2.2.3. Display outlook
- 2.2.4. End use outlook
- 2.2.5. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Cardiovascular Ultrasound Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of cardiovascular diseases
- 3.2.1.2. High adoption of preventive healthcare
- 3.2.1.3. Technological advancements
- 3.2.2. Market restraint analysis
- 3.2.2.1. Slower treatment
- 3.2.2.2. Reimbursement policies
- 3.3. Cardiovascular Ultrasound Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Cardiovascular Ultrasound Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Cardiovascular Ultrasound Type Market Movement Analysis
- 4.3. Global Cardiovascular Ultrasound Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 4.4. Transthoracic echocardiography
- 4.4.1. Transthoracic echocardiography market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Transesophageal echocardiography
- 4.5.1. Transesophageal echocardiography market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Fetal echocardiography
- 4.6.1. Fetal echocardiography market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7. Others
- 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Cardiovascular Ultrasound Market: Technology Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Cardiovascular Ultrasound Technology Market Movement Analysis
- 5.3. Global Cardiovascular Ultrasound Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
- 5.4. 2D
- 5.4.1. 2D market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. 3D/4D
- 5.5.1. 3D/4D market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Doppler
- 5.6.1. Doppler market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Cardiovascular Ultrasound Market: Display Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Cardiovascular Ultrasound Display Market Movement Analysis
- 6.3. Global Cardiovascular Ultrasound Market Size & Trend Analysis, by Display, 2018 to 2030 (USD Million)
- 6.4. B/W
- 6.4.1. B/W market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Color
- 6.5.1. Color market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Cardiovascular Ultrasound Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Global Cardiovascular Ultrasound End Use Market Movement Analysis
- 7.3. Global Cardiovascular Ultrasound Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 7.4. Hospitals
- 7.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5. Diagnostic Centers
- 7.5.1. Diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Ambulatory Care Centers
- 7.6.1. Ambulatory care centers market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. Others
- 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Cardiovascular Ultrasound Market: Regional Estimates & Trend Analysis By Type, Technology, Display, End Use
- 8.1. Regional Market Share Analysis, 2023 & 2030
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 8.5. North America
- 8.5.1. U.S.
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Competitive scenario
- 8.5.1.3. Regulatory framework
- 8.5.1.4. Reimbursement structure
- 8.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.2. Canada
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Competitive scenario
- 8.5.2.3. Regulatory framework
- 8.5.2.4. Reimbursement structure
- 8.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.3. Mexico
- 8.5.3.1. Key country dynamics
- 8.5.3.2. Competitive scenario
- 8.5.3.3. Regulatory framework
- 8.5.3.4. Reimbursement structure
- 8.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6. Europe
- 8.6.1. UK
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Competitive scenario
- 8.6.1.3. Regulatory framework
- 8.6.1.4. Reimbursement structure
- 8.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.2. Germany
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Competitive scenario
- 8.6.2.3. Regulatory framework
- 8.6.2.4. Reimbursement structure
- 8.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.3. France
- 8.6.3.1. Key country dynamics
- 8.6.3.2. Competitive scenario
- 8.6.3.3. Regulatory framework
- 8.6.3.4. Reimbursement structure
- 8.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.4. Italy
- 8.6.4.1. Key country dynamics
- 8.6.4.2. Competitive scenario
- 8.6.4.3. Regulatory framework
- 8.6.4.4. Reimbursement structure
- 8.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.5. Spain
- 8.6.5.1. Key country dynamics
- 8.6.5.2. Competitive scenario
- 8.6.5.3. Regulatory framework
- 8.6.5.4. Reimbursement structure
- 8.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.6. Norway
- 8.6.6.1. Key country dynamics
- 8.6.6.2. Competitive scenario
- 8.6.6.3. Regulatory framework
- 8.6.6.4. Reimbursement structure
- 8.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.7. Sweden
- 8.6.7.1. Key country dynamics
- 8.6.7.2. Competitive scenario
- 8.6.7.3. Regulatory framework
- 8.6.7.4. Reimbursement structure
- 8.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.8. Denmark
- 8.6.8.1. Key country dynamics
- 8.6.8.2. Competitive scenario
- 8.6.8.3. Regulatory framework
- 8.6.8.4. Reimbursement structure
- 8.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7. Asia Pacific
- 8.7.1. Japan
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Competitive scenario
- 8.7.1.3. Regulatory framework
- 8.7.1.4. Reimbursement structure
- 8.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.2. China
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Competitive scenario
- 8.7.2.3. Regulatory framework
- 8.7.2.4. Reimbursement structure
- 8.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.3. India
- 8.7.3.1. Key country dynamics
- 8.7.3.2. Competitive scenario
- 8.7.3.3. Regulatory framework
- 8.7.3.4. Reimbursement structure
- 8.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.4. Australia
- 8.7.4.1. Key country dynamics
- 8.7.4.2. Competitive scenario
- 8.7.4.3. Regulatory framework
- 8.7.4.4. Reimbursement structure
- 8.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.5. South Korea
- 8.7.5.1. Key country dynamics
- 8.7.5.2. Competitive scenario
- 8.7.5.3. Regulatory framework
- 8.7.5.4. Reimbursement structure
- 8.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.6. Thailand
- 8.7.6.1. Key country dynamics
- 8.7.6.2. Competitive scenario
- 8.7.6.3. Regulatory framework
- 8.7.6.4. Reimbursement structure
- 8.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8. Latin America
- 8.8.1. Brazil
- 8.8.1.1. Key country dynamics
- 8.8.1.2. Competitive scenario
- 8.8.1.3. Regulatory framework
- 8.8.1.4. Reimbursement structure
- 8.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.2. Argentina
- 8.8.2.1. Key country dynamics
- 8.8.2.2. Competitive scenario
- 8.8.2.3. Regulatory framework
- 8.8.2.4. Reimbursement structure
- 8.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9. MEA
- 8.9.1. South Africa
- 8.9.1.1. Key country dynamics
- 8.9.1.2. Competitive scenario
- 8.9.1.3. Regulatory framework
- 8.9.1.4. Reimbursement structure
- 8.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.2. Saudi Arabia
- 8.9.2.1. Key country dynamics
- 8.9.2.2. Competitive scenario
- 8.9.2.3. Regulatory framework
- 8.9.2.4. Reimbursement structure
- 8.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.3. UAE
- 8.9.3.1. Key country dynamics
- 8.9.3.2. Competitive scenario
- 8.9.3.3. Regulatory framework
- 8.9.3.4. Reimbursement structure
- 8.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.4. Kuwait
- 8.9.4.1. Key country dynamics
- 8.9.4.2. Competitive scenario
- 8.9.4.3. Regulatory framework
- 8.9.4.4. Reimbursement structure
- 8.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Key company market share analysis, 2023
- 9.4. Company Position Analysis
- 9.5. Company Categorization (Emerging Players, Innovators and Leaders
- 9.6. Company Profiles
- 9.6.1. Koninklijke Philips N.V.
- 9.6.1.1. Company overview
- 9.6.1.2. Financial performance
- 9.6.1.3. Product benchmarking
- 9.6.1.4. Strategic initiatives
- 9.6.2. GE Healthcare
- 9.6.2.1. Company overview
- 9.6.2.2. Financial performance
- 9.6.2.3. Product benchmarking
- 9.6.2.4. Strategic initiatives
- 9.6.3. Siemens Healthineers AG
- 9.6.3.1. Company overview
- 9.6.3.2. Financial performance
- 9.6.3.3. Product benchmarking
- 9.6.3.4. Strategic initiatives
- 9.6.4. Canon Medical Systems
- 9.6.4.1. Company overview
- 9.6.4.2. Financial performance
- 9.6.4.3. Product benchmarking
- 9.6.4.4. Strategic initiatives
- 9.6.5. Mindray Medical International Limited
- 9.6.5.1. Company overview
- 9.6.5.2. Financial performance
- 9.6.5.3. Product benchmarking
- 9.6.5.4. Strategic initiatives
- 9.6.6. Samsung Medison Co., Ltd.
- 9.6.6.1. Company overview
- 9.6.6.2. Financial performance
- 9.6.6.3. Product benchmarking
- 9.6.6.4. Strategic initiatives
- 9.6.7. FUJIFILM SonoSite, Inc.,
- 9.6.7.1. Company overview
- 9.6.7.2. Financial performance
- 9.6.7.3. Product benchmarking
- 9.6.7.4. Strategic initiatives
- 9.6.8. Konica Minolta Inc.
- 9.6.8.1. Company overview
- 9.6.8.2. Financial performance
- 9.6.8.3. Product benchmarking
- 9.6.8.4. Strategic initiatives
- 9.6.9. Esaote
- 9.6.9.1. Company overview
- 9.6.9.2. Financial performance
- 9.6.9.3. Product benchmarking
- 9.6.9.4. Strategic initiatives
- 9.6.10. Trivitron Healthcare
- 9.6.10.1. Company overview
- 9.6.10.2. Financial performance
- 9.6.10.3. Product benchmarking
- 9.6.10.4. Strategic initiatives